GLTSCR1 deficiency promotes colorectal cancer development through regulating non-homologous end joining.

Oncogene

Department of Pathology and International Institutes of Medicine, The Fourth Affiliated Hospital (Yiwu), Zhejiang University School of Medicine, Hangzhou, 310058, China.

Published: November 2024

AI Article Synopsis

  • - Non-homologous end joining (NHEJ) is a key DNA repair pathway that can lead to genomic instability and is linked to cancer, particularly colorectal cancer (CRC), but how it interacts with chromatin remodeling is not fully understood.
  • - The study highlights that a deficiency in the protein GLTSCR1 enhances NHEJ repair efficiency in CRC cells, making them more resistant to DNA damage by affecting the assembly of the GBAF chromatin remodeling complex and leading to changes in gene expression.
  • - GLTSCR1 deficiency disrupts the normal regulation of NHEJ-related genes and is essential for CRC progression, suggesting the need for different treatment approaches depending on the GLTSCR1 status in CRC patients.

Article Abstract

Non-homologous end joining (NHEJ), as one major pathway of DNA double-strand break (DSB) repair, could cause genomic instability, which plays pivotal roles in cancer development. While, chromatin remodeling complexes dictate the selection and orchestration of DSB repair pathways by regulating chromatin dynamics. However, the crosstalk between NHEJ and chromatin remodeling in cancer progress remains unclear. In this study, deficiency of GLTSCR1 causes resistance to DNA damage in colorectal cancer (CRC) cells by promoting NHEJ repair efficiency. Mechanistically, GLTSCR1 interacts with BRD9 to engage in the assembly of the non-canonical BAF complex (GBAF). However, GLTSCR1 deficiency disrupts GBAF and triggers the ubiquitination degradation of BRD9. Furthermore, GLTSCR1 deficiency causes aberrant opening in the promoter region of NHEJ repair-associated genes, which promotes CRC development. While, GLTSCR1 and its binding partner BRD9 are not directly involved in assembling NHEJ repair machinery; instead, they regulate the DNA accessibility of NHEJ repair-associated genes. Collectively, our findings confirm GLTSCR1 deficiency as a critical regulatory event of the NHEJ pathway in CRC development, which might require different therapeutic strategy for GLTSCR1 wild-type and mutant CRC.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-024-03179-xDOI Listing

Publication Analysis

Top Keywords

gltscr1 deficiency
16
gltscr1
8
colorectal cancer
8
cancer development
8
non-homologous joining
8
dsb repair
8
chromatin remodeling
8
nhej repair
8
nhej repair-associated
8
repair-associated genes
8

Similar Publications

GLTSCR1 deficiency promotes colorectal cancer development through regulating non-homologous end joining.

Oncogene

November 2024

Department of Pathology and International Institutes of Medicine, The Fourth Affiliated Hospital (Yiwu), Zhejiang University School of Medicine, Hangzhou, 310058, China.

Article Synopsis
  • - Non-homologous end joining (NHEJ) is a key DNA repair pathway that can lead to genomic instability and is linked to cancer, particularly colorectal cancer (CRC), but how it interacts with chromatin remodeling is not fully understood.
  • - The study highlights that a deficiency in the protein GLTSCR1 enhances NHEJ repair efficiency in CRC cells, making them more resistant to DNA damage by affecting the assembly of the GBAF chromatin remodeling complex and leading to changes in gene expression.
  • - GLTSCR1 deficiency disrupts the normal regulation of NHEJ-related genes and is essential for CRC progression, suggesting the need for different treatment approaches depending on the GLTSCR1 status in CRC patients.
View Article and Find Full Text PDF

BICRA, a SWI/SNF Complex Member, Is Associated with BAF-Disorder Related Phenotypes in Humans and Model Organisms.

Am J Hum Genet

December 2020

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX 77030, USA; Program in Developmental Biology, Baylor College of Medicine, Houston, TX 77030, USA; Institute of Neuroscience, University of Oregon, Eugene, OR 97403, USA; Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX 77030, USA. Electronic address:

SWI/SNF-related intellectual disability disorders (SSRIDDs) are rare neurodevelopmental disorders characterized by developmental disability, coarse facial features, and fifth digit/nail hypoplasia that are caused by pathogenic variants in genes that encode for members of the SWI/SNF (or BAF) family of chromatin remodeling complexes. We have identified 12 individuals with rare variants (10 loss-of-function, 2 missense) in the BICRA (BRD4 interacting chromatin remodeling complex-associated protein) gene, also known as GLTSCR1, which encodes a subunit of the non-canonical BAF (ncBAF) complex. These individuals exhibited neurodevelopmental phenotypes that include developmental delay, intellectual disability, autism spectrum disorder, and behavioral abnormalities as well as dysmorphic features.

View Article and Find Full Text PDF

Frameshift mutations frequently occur in colorectal cancer (CRC) with microsatellite instability (MSI), but the nature and biological function of many MSI-associated mutations remain elusive. Here, an MSI frameshift mutation is identified in glioma tumor suppressor candidate region gene 1 () that produces two C-terminal-truncated proteins. Additionally, is verified as a tumor suppressor that inhibits CRC metastasis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!